Transdermal & Implantable Market Research Reports & Industry Analysis
The transdermal/transmucosal drug delivery market is two-fold. First of all, it encompasses drug delivery technology and the revenues earned from licensing that technology. Secondly, it encompasses the pharmaceutical arena as well.
Implantable drug delivery is used as depot formulations either to limit high drug concentrations to the immediate area surrounding the pathology or to provide sustained drug release for systemic therapy. Clinically, implant systems have been used in situations where chronic therapy is indicated, such as hormone replacement therapy and chemical castration in the treatment of prostate cancer. Implants are used for the delivery of anticancer agents as they are able to confine potentially toxic anticancer drugs to tumor sites and also allow sustained drug release.
Reports in this category include a focus on drug delivery markets.
Transdermal & Implantable Industry Research & Market Reports
-
Smoking Cessation Aids
... at a CAGR of 6.2% over the analysis period 2024-2030. Nicotine Replacement Therapy, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$15.9 Billion by the end ... Read More
-
Medical Sensors Market, By Sensor Type (Temperature Sensor, ECG Sensor, Blood Glucose Sensor, Biosensor, Motion Sensor, and Others), By Mode of Delivery (Skin-attached, Wearable, Implantable, and Others), By Application (Remote Patient Monitoring, Fitness Monitoring, Chronic Disease Management, Drug Delivery, and Others), By End User (Hospitals & Clinics, Home Healthcare, Fitness and Wellness Centers, Clinical and Diagnostic Laboratories, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... has been witnessing steady growth over the past few years. Medical sensors play a crucial role in patient monitoring in healthcare facilities and are growing in importance due to increasing cases of chronic diseases across ... Read More
-
The 2026-2031 World Outlook for Active Transdermal Drug Delivery Devices
... country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... Read More
-
The 2026-2031 World Outlook for Contraceptive Implantable Drug Delivery Devices
... country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... Read More
-
The 2026-2031 World Outlook for Drug Delivery Systems
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Advanced Drug Deliveries
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
Advanced Drug Delivery Systems – A Global Market Overview
... drug delivery, enhancing therapeutic outcomes while minimizing adverse effects. These systems improve drug solubility, bioavailability, and therapeutic effects while reducing side effects and dosing frequency, thus improving patient compliance and health outcomes. ADDS utilizes various ... Read More
-
Global Drug Delivery Devices Market - 2025-2033
... period 2025-2033. The global drug delivery devices market is undergoing rapid evolution, driven by technological innovation, the rising burden of chronic diseases, and a stronger focus on patient-centered care. Advanced solutions such as smart inhalers, ... Read More
-
Transdermal Drug Delivery
... at a CAGR of 16.6% over the analysis period 2024-2030. Passive, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$123.5 Billion by the end of the ... Read More
-
Implantable Drug Delivery Devices
... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Contraceptive Implants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$9.8 Billion by the ... Read More
-
Implantable Ports
... CAGR of 3.1% over the analysis period 2024-2030. Single-Lumen, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$186.6 Million by the end of the analysis period. ... Read More
-
Non-opioid Pain Patch
... at a CAGR of 2.2% over the analysis period 2024-2030. Lidocaine Patches, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Transdermal Scopolamine
... CAGR of 5.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$141.9 Million While China is Forecast to Grow at 5.1% CAGR The Transdermal Scopolamine market in the U.S. is estimated at ... Read More
-
Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030
... the geriatric demographic, coupled with a notable increase in patients suffering from chronic conditions such as diabetes and cardiovascular diseases, is projected to drive the market for drug-device combination products significantly. Additionally, the steady rise ... Read More
-
Global Bioresorbable Ophthalmic Drug Delivery System Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
... million by 2031 with a CAGR of 6.4% during review period. Bioresorbable implants are inserted into the patient’s eye and safely absorbed by the body over time. The global pharmaceutical market is 1475 billion USD ... Read More
-
Global Biodurable Ophthalmic Drug Delivery System Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
... million by 2031 with a CAGR of 5.7% during review period. Biodurable implants do not break down over time and may be removed or refilled once the treatment is complete. The global pharmaceutical market is ... Read More
-
Global Wearable Patch Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Transdermal Skin Patches Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... US$ 12.02 Bn by 2032, registering a CAGR of 5.39% during the forecast period. This growth is being propelled by advancements in pharmaceutical technology, a rise in chronic disease cases, and increased regulatory support for ... Read More
-
Global New Drug Delivery Systems Market 2025-2029
... the new drug delivery systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Implantable Drug Delivery Devices Global Market Report 2025
... delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Plastics In Personalized Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (PLA, PLGA, PEG, PU, PEEK), By End Use (Pharmaceuticals & Drug Delivery, Medical Devices & Implants, Healthcare & Clinics), By Region, And Segment Forecasts, 2025 - 2030
... 2025 to 2030, according to a new report by Grand View Research, Inc. The plastics in personalized drug delivery systems industry is a crucial segment of the global healthcare and pharmaceutical industry, driven by the ... Read More
-
Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Small Intestine, Large Intestine, Stomach), End User (Hospitals, Diagnostic Centers), and Region - Global Forecast to 2030
... USD 1.30 billion by 2030 from USD 0.69 billion in 2024, at a CAGR of 11.2% during the forecast period. According to the American Cancer Society (ACS), in 2024, there were 1,52,810 new cases of ... Read More
-
Global Long-Acting Drug Delivery Technologies and Services Market: Focus on Technology, Dosage Form, Type of Molecule Delivered, Material, Distribution Channel, and Region - Analysis and Forecast, 2025-2035
... expansion reflects the growing recognition of long-acting drug delivery systems as a highly effective approach to treatment. Key drivers of this growth include the increasing prevalence of chronic diseases, continuous advancements in long-acting drug delivery ... Read More
-
Long-Acting Drug Delivery Technologies and Services Market by Compatible Dosage Form
... 4.62 billion by 2035, at a CAGR of 13.1% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Principle Manipulation of drug release from delivery ... Read More
-
2025 United States Electronic Drug Delivery Systems Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Forecast (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market. The product or service category is within the Medical Device Manufacturing industry. NAICS ELE2730 Read More
Research Assistance
